Target intelligence / Profile preview

HSPC023 protein pseudogene (HSPC023)

Target
HSPC023
Molecular classification
Pseudogene, Processed or unprocessed pseudogene
01

Overview

The **HSPC023 protein pseudogene** (ENSG00000213247) is classified as a pseudogene, a segment of genomic DNA resembling a known gene (here, HSPC023 protein) but generally considered nonfunctional due to mutations that prevent protein expression. Pseudogenes originate by gene duplication or retrotransposition, after which disabling mutations accumulate[1][6][4]. Although once labeled “junk DNA,” some pseudogenes produce noncoding RNA transcripts capable of regulating gene expression indirectly, for example by acting as decoys for microRNAs (miRNAs) or participating in other gene regulatory networks; however, there is no evidence that the HSPC023 protein pseudogene is functional in this manner[1][3][6]. It is not recognized as a therapeutic target, receptor, enzyme, transporter, or transcription factor; nor does it have any known aliases or biomarker/drug associations[4]. The “is_incorrect” flag is set to true because pseudogenes are not considered actionable therapeutic targets and generally lack sufficient structural/functional information to populate standard drug discovery databases[5][4].

Other names
ENSG00000213247
02

Biological functions

Regulatory RNA molecule (possible role as competitive endogenous RNA or miRNA decoy, typical for some pseudogenes, though no specific function demonstrated for HSPC023 protein pseudogene)Other (no direct evidence for a protein-coding or functional RNA role for this specific pseudogene)
03

Disease associations

Other (pseudogenes can sometimes participate in gene regulation in cancer or other diseases, but there is no specific evidence for a disease role for HSPC023 protein pseudogene)

Beyond the preview

Go deeper on HSPC023 protein pseudogene (HSPC023).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HSPC023 protein pseudogene (HSPC023).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call